In an unprecedented approach, p-n heterojunction nanosheets comprising $5 nm thick p-type MoS 2 nanoplates integrated onto n-type nitrogen doped reduced graphene oxide (n-rGO) have been 
Introduction
The p-n heterojunction between semiconductor materials of dissimilar band gaps can be used to engineer the electronic energy bands and therefore provide real time control over the electronic conductivity across graded or abrupt interfaces.
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Apart from electronic and optoelectronic device applications ranging from transistors 2 and solar cells 3 to lasers, 4 where the p-n junction acts as the basic building block, the unorthodox use of heterostructures consisting of multiple heterojunctions is highly intriguing whereby the separated charge carriers can be utilized for chemical and biochemical transformations. For instance NIR light absorbing p-n heterostructures can be employed in PDT with the advantages of minimal side effect. 5 In general PDT employs NIR light with far more penetration depth inside so biological tissues than UV/visible light, where the photosensitizer subsequently transfers its energy to molecular oxygen to create ROS for selective destruction of key cellular components via apoptosis and necrosis mediated pathways. 6, 7 In the case of the p-n heterojunction, the excited electrons in the conduction band can react with O 2 to form superoxide anion radicals (O 2 À c) and holes in the valence band can react with H 2 O to form hydroxyl radicals, 8 both of which are extremely cytotoxic towards cancer cells. Recently Au-CuS heterojunction NPs have been employed to produce cytotoxic ROS, 9 and BiOI@Bi 2 S 3 @bovine serum albumin heterojunction NPs were reported as radio/photo-sensitizers for cancer therapy.
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Although Tian, Bezanilla and co-workers have demonstrated free-standing coaxial p-type/intrinsic/n-type silicon nanowires in neuromodulation via a photoelectrochemical process, 11 to the best of our knowledge, the strategy of employing a nanoscale p-n heterojunction in photodynamic cancer therapy has not been explored. In the past, n-type nitrogen doped reduced graphene oxide (n-rGO) supported p-type MoS 2 nanoplates have been used in photochemical/photoelectrochemical hydrogen generation. 8 This particular system has remarkable potential in PDT; however their large size restricts the intended biomedical applications. Moreover, the development of a photosensitizing nanosystem that can alleviate tumour hypoxia is extremely challenging.
We use the p-n heterojunction concept to develop a PDT agent consisting of poly(ethylene glycol) modied (PEGylated), MnO 2 NP decorated p-MoS 2 /n-rGO nanosheets (p-MoS 2 /n-rGOMnO 2 -PEG). The nanosheet structure has the advantages of a large surface area and rapid absorption of NIR light.
12 While the coordination of a semiconductor like p-MoS 2 on n-rGO improves photogeneration of electron-hole pairs, 8, 13 the heterojunction promotes the migration of electrons and holes, and enhances the separation of charge carriers upon NIR light irradiation. The role of MnO 2 is to overcome the hypoxic conditions prevalent within the tumour microenvironment, by generating O 2 in the presence of a high level of H 2 O 2 (100 mM to 1 mM) via the Fenton reaction. [14] [15] [16] [17] In vitro studies clearly demonstrate the PDT efficacy of this nanosystem that can overcome the basic limitations of common photosensitizers such as absorption of light in the UV-visible region, low photostability, low cellular uptake, non-uniform distribution within cancerous tissues, poor hydrophilicity and poor resistance to enzymatic degradation.
18 ROS generation within the tumour tissues could be controllably achieved by this O 2 self-sufficient nanoplatform under 980 nm NIR irradiation at 0.4 W cm À2 power density.
Results and discussion
The top panel in Scheme 1 shows the synthesis methodology of p-MoS 2 /n-rGO-MnO 2 -PEG heterojunction nanosheets through liquid exfoliation of GO and hydrothermal reaction with Na 2 -MoO 4 $2H 2 O and thiourea, followed by nitrogen doping and subsequent anchoring of MnO 2 NPs. Herein thiourea not only acts as a source of sulphur to form MoS 2 but also acts as a reducing agent for GO to rGO conversion (see the Experimental section, ESI †). In the fourth step, lipoic acid termination of PEG (LA-PEG 2000 ) provides better biocompatibility and colloidal stability in physiological solution (Fig. S1 †) . 19 The lower panel of Scheme 1 shows the conceptual basis of this work whereby the PEGylated p-n heterojunction nanosheets serve as an NIR light triggered photosensitizer equipped with the capability to separate electrons and holes. Once the surface modulated nanosheets are internalized within the blood vessel and accumulated at the tumour area, endogenous H 2 O 2 inu-enced and MnO 2 NP triggered O 2 generation is balanced by its transformation into cytotoxic ROS components such as hydroxyl radicals ($OH) and singlet oxygen ( 1 O 2 ) by the separated charge carriers, analogous to photocatalytic water splitting. In order to understand the relevance of each component in the designed PDT agent, three PDT nanosystems were studied, (i) MoS 2 /rGO-PEG nanosheets, where MoS 2 nanoplates are grown in situ on undoped rGO, (ii) p-MoS 2 /n-rGO-PEG nanosheets, where p-type MoS 2 nanoplates are grown in situ on nitrogen doped n-rGO, and nally (iii) p-MoS 2 /n-rGO-MnO 2 -PEG, where MnO 2 NPs are decorated onto p-MoS 2 /n-rGO heterojunction nanosheets. Exfoliation of GO nanosheets reduces its average length and thickness from $500 nm and 5 nm for the as-synthesized free-standing GO to $170 nm and $2.8 nm for the exfoliated GO nanosheets, respectively (Fig. S2 †) . While nitrogen doping in rGO does not signicantly alter the above dimensions, the rGO/n-rGO nanosheets suppress the aggregation of MoS 2 nanoplates which otherwise aggregate in ower-like clusters (Fig. S2 †) . Similarly Fig. 1a shows that the pMoS 2 /n-rGO-PEG nanosheets have a mean lateral dimension of $180 nm, along with 5-12 nm long strips of p-MoS 2 nanoplates grown on n-rGO, as seen from the lattice fringes in Structural information on the nanosheets at different stages was obtained from powder X-ray diffraction (PXRD; Fig. 1f ) and Raman spectral analysis (Fig. 1g ). Both the bare and GO immobilized MoS 2 crystallize in the hexagonal phase (JCPDS card no. 37-1492). The successful conversion of GO to rGO by thiourea is evident from the shi of the (002) than the disordered (D) band at 1373 cm À1 facilitating a conducting channel for movement of charge carriers. 26 To investigate the semiconducting nature, the nanosheets were deposited on uorine doped tin oxide (FTO) glass substrates (see the Experimental section for details †) and electrochemical impedance spectroscopy (EIS) measurements were performed at an AC frequency of 10 kHz in 1 M NaOH electrolyte solution using three-electrode electrochemical cells. As shown from the MottSchottky (M-S) plots in Fig. 1h to 1 , both MoS 2 and MoS 2 /rGO-PEG show a negative slope in the M-S plot (1/C 2 vs. potential (V), C stands for capacitance) suggesting p-type character of the nanosheets whereas n-rGO shows a positive slope indicating n-type behaviour. With p-MoS 2 /n-rGO-PEG and p-MoS 2 /n-rGOMnO 2 -PEG nanosheets, the M-S plots represent an inverted "V-shape" behaviour validating their p-n heterojunction characteristics.
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The betting optical properties of these nanosheets attest to their eligibility to act as a PDT agent, the most important being their absorption in the NIR region, 700-1100 nm. At an equivalent concentration of 60 mg mL À1 , the initial observation from the optical absorbance spectra in Fig. 2a is the widening of absorbance from GO to rGO in the composite nanosheets, due to improved p-conjugation. Under NIR irradiation at 980 nm, the DCF uorescence intensity at 522 nm increases 19 fold with p-MoS 2 / n-rGO-MnO 2 -PEG as compared to MoS 2 /rGO-PEG nanosheets (Fig. S7 †) , suggesting an effective ROS production. Since the concentration range of endogenous H 2 O 2 in most tumour tissues is 10-100 mM, the dissolved oxygen (DO) production by p-MoS 2 /n-rGO-MnO 2 -PEG nanosheets in 100 mM H 2 O 2 solution was measured with a portable DO meter (Fig. 2d) . Since MnO 2 NPs can catalytically trigger the decomposition of intracellular H 2 O 2 to O 2 and H 2 O, upon adding different concentrations of the nanosheets, oxygen is produced rapidly (Fig. 2d inset) ; thus DO increases proportionally with nanosheet concentration. In order to simulate a cellular hypoxic environment, the oxygen generating properties of these nanosheets were also evaluated in N 2 saturated solutions at different pH ( Fig. S8a and b †) . Among these nanosheets, p-MoS 2 /n-rGO-MnO 2 -PEG efficiently generates enough oxygen that could alleviate the hypoxia conditions inside tumour tissues. With 20 mg mL À1 p-MoS 2 /nrGO-MnO 2 -PEG nanosheets, the amount of dissolved O 2 is 6.4 mg L À1 under normoxic conditions (Fig. 2d) as compared to 4.9 mg L À1 when the solution is saturated with N 2 (Fig. S8a †) .
The O 2 generation triggered by p-MoS 2 /n-rGO-MnO 2 -PEG is faster at pH 5.5 than at pH 7.4 ( Fig. S8b †) (Fig. S10 †) . The cell viability reduces further to 14% at 120 mg mL À1 , which is a usual occurrence with increasing concentration of the PDT agents. The presence of MnO 2 NPs helps to overcome tumour hypoxia, 10 such that at 120 mg mL À1 concentration, the in vitro cell killing efficacy is 3-fold and more than 5-fold as compared to that of MoS 2 /rGO-PEG and p-MoS 2 /n-rGO-PEG, respectively. Cell killing can be further enhanced by increasing the laser power density (Fig. S11 †) . However since the threshold temperature for cell apoptosis is about 43 C,
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temperature elevation was controlled to less than 40 C by tuning the concentration, limiting the laser power density and irradiation time in order to minimize the photothermal effect and maximize the PDT effect. Accordingly, the nanosheet concentration was xed at 60 mg mL À1 with 5 min laser irradiation at 0.4 W cm À2 power density (Fig. 3b) where the cell killing efficiency of p-MoS 2 /n-rGO-MnO 2 -PEG is still 3.3 and 2.5 times higher than that of MoS 2 /rGO-PEG and p-MoS 2 /n-rGO-PEG, respectively. However a mild photothermal effect can increase the efficiency of nanosheet uptake by the cells, 33 as well as enhancing the photocatalysis process through improved mobility of photogenerated charge carriers.
34 When a 1 O 2 quencher such as 50 mM NaN 3 is added, cell viability shows an improving trend even in the presence of laser irradiation, highlighting the importance of 1 O 2 induced oxidative damage for cancer cell death.
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The promising therapeutic PDT efficacy of these nanosheets was evaluated by monitoring the uorescence microscope images obtained by co-staining with uorescein diacetate for live cells and propidium iodide (PI) for dead cells (Fig. 3c and S12 †). Without NIR irradiation the cells are not visibly damaged by the biocompatible nanosheets as evident from the vivid green uorescence. With NIR irradiation the merged uores-cence images show a substantial increase in red uorescence. From the uorescence microscopy images of 1500 cells it is observed that more than 90% of the cells are damaged by pMoS 2 /n-rGO-MnO 2 -PEG as compared to $25% and $8% damaged cells for p-MoS 2 /n-rGO-PEG and MoS 2 /rGO-PEG, respectively. Furthermore, the intracellular ROS production was investigated by uorescence microscopy with cell permeable green uorescent ROS indicator DCFDA. As observed in Fig. 3d , both NIR irradiation and the p-n heterojunction nanosheets are required to increase the intracellular ROS yield in HeLa cells by intracellular electron-hole pair separation. A remarkable green uorescence of DCF is observed with p-MoS 2 /n-rGO-MnO 2 -PEG and p-MoS 2 /n-rGO-PEG whereas the green uorescence is negligible for control cells and MoS 2 /rGO-PEG. Obviously, upon adding the NaN 3 scavenger the uorescence intensity decreases. Flow cytometry reveals a remarkable shi in the DCF uores-cence intensity (Fig. 3d(E) ) wherein the quantied uorescence intensities of DCF with NIR treated p-MoS 2 /n-rGO-MnO 2 -PEG, p-MoS 2 /n-rGO-PEG, and MoS 2 /rGO-PEG nanosheets are 14, 8, and 3-fold more as compared to only NIR treated samples, respectively.
To understand the mechanistic cell death either by apoptotic or necrotic pathways, ow cytometry was employed with an Alexa Fluor 488 Annexin V/dead cell apoptosis kit. The involvement of dual staining, green emission from Alexa Fluor 488-Annexin V, affinity to bind phosphatidyl serine and DNA binding PI dye with red emission combine to identify the cellular apoptotic (early or late) or necrotic pathways. During the early stage of apoptosis, cells bind to Alexa Fluor 488-Annexin V and change their phospholipid asymmetry to display green uorescence while necrotic cells bind only with PI. In late apoptosis the cells lose their membrane integrity and display dual positive emission. Under NIR irradiation for 5 min, the population of apoptotic and dead cells for p-MoS 2 /n-rGO-MnO 2 -PEG is $90%, much higher than $21% for p-MoS 2 /n-rGO-PEG and $5% for MoS 2 /rGO-PEG (Fig. 4) . The minimal cell population in the necrosis stage suggests that the decrease in cell membrane integrity occurs via an apoptosis pathway. The statistical data of cell population at various stages of cellular damage validate the effectiveness of pMoS 2 /n-rGO-MnO 2 -PEG nanosheets in producing ROS in HeLa cells activated by intracellular H 2 O 2 and NIR irradiation. Most importantly these p-n heterojunction nanosheets act as active photosensitizers wherein the charge carriers can be separated and along with the advantage of MnO 2 NPs in producing intracellular ROS, together make this system an exceptional PDT agent, as demonstrated in vitro.
Notwithstanding the unprecedented efficacy of p-n heterojunction nanosheets towards PDT, demonstrated in vitro, there are complexities that abound within the biomicroenvironment of animal systems, primarily associated with the dynamic nonspecic interactions between the nanostructures and biological entities. Starting from in vivo cellular internalization to bioclearance, the complicacies associated with the designed PDT agent involve their size, shape, agglomeration, dissolution, doses, protein adsorption, biodegradation, surface reactivity and macrophage uptake. 36 At the foremost, precise nanosheet doses are required to prevent heart blockage. Moreover due to formation of a protein corona complex, the nanosheets might be engulfed by macrophage cells. Also bioclearance of the nanosheets through excretion and biodegradation processes will depend on the appropriate nanosheet dimensions and surface chemistry wherein rapid clearance may lead to overaccumulation in non-targeted organs. Taking these perplexities into account, the in vivo experiments will be the topic of our future study in order to evaluate the toxicity, biodistribution, body clearance and mechanistic PDT efficacy of p-n heterojunction nanosheets in the native biomicroenvironment.
Conclusions
In summary, we successfully designed a unique twodimensional hybrid nanoplatform based on PEGylation of MnO 2 decorated p-MoS 2 /n-rGO heterojunction nanosheets (p-MoS 2 /n-rGO-MnO 2 -PEG). These hybrid nanosheets show unprecedented performance as an O 2 self-sufficient NIR lighttriggered PDT agent. The as-synthesized nanosheets retain their excellent colloidal stability in water, phosphate buffered saline with different pH and in biological media. While the p-n heterojunction directs NIR light triggered generation and separation of electron-hole pairs that could increase the production of ROS via photocatalysis, MnO 2 NPs increase intracellular O 2 by the reaction with endogenous H 2 O 2 to overcome the hypoxic conditions in the cellular microenvironment. Compared to p-MoS 2 /n-rGO-PEG and MoS 2 /rGO-PEG, the p-MoS 2 /n-rGO-MnO 2 -PEG nanosheets show enhanced DCF uorescence and reveal hypoxia induced increased apoptosis under NIR light irradiation. Since the p-MoS 2 /n-rGO-MnO 2 -PEG nanosheets have been demonstrated in vitro to be an efficient PDT photosensitizer for cancer therapy, our strategy can be applied in developing other nanoscale heterojunction materials for biomedical applications. 
